and provide a rationale and direction for therapy in heroin use, a behavioral model would appear to be distinctly superior to others, including the communicable disease or clinical model. References 1. Morton, F. L. A County Health Department's Role in Drug Programs. HSMHA Health Rep. 86:1069-1076, 1971. 2. Parsons, T. The Social System, pp. 436-439. The Free Press, New York, 1951. 3. Torrey, E. F. The Death of Psychiatry, pp. 148-150. Chilton Book Company, Radnor, PA, 1974. 4. Solomon, R. L. Punishment. Am. Psychol. 19:239-253, 1964. 5. Cautela, J. R. Covert Sensitization. Psychol. Rep. 74:459-468, 1967.

Frank L. Morton, MD, MPH Behavior Therapy Institute White Plains, NY

RESPONSE TO DR. MORTON'S LETTER I appreciate your taking the time to comment on my article. Let me respond with the following points: First, the article was intended as a discussion of one way of approaching research in the problem of drug abuse. It was not my intent to suggest that the epidemiologic model is the only model or even the best model. Nor was it the intent of the article to review all models of drug addiction. I believe the epidemiologic model is broad enough "to accommodate all aspects of a

social or health interest area." It has not contributed substantially to a better understanding of etiology because studies of that sort are very complex to design and expensive to fund. However, the ability of the epidemiologic approach to suggest the etiology of other diseases (smoking and lung cancer, for example) has been

shown repeatedly. The similarity between drug abuse and other phenomena which spread by "social diffusion" does not detract from the utility of this observation in studying drug abuse. It may limit the importance of such observations with

regard to elucidating etiology, but it does form the basis of an analytic approach to the problem which permits a quantitiative assessment of drug abuse trends. In this regard, other models of drug abuse (including the behavioral model) are relatively weak. Does that mean they should be characterized as "limited or half-models" and discarded as being deficient? I think not. In my opinion, the medical model does not demand relegation of the addict to a dependent role, nor does it require that the process under consideration have a single etiology or a single form of therapy. Medicine abounds with examples in which the patients take an active role in the treatment of their illnesses, in which diseases have multiple etiologies. Problems like drug abuse are quite complex, and not suited to overly simplistic analytic techniques. We must be flexible enough to approach the problem from many different points of view, incorporating the strengths of different models and different methodologies, if we are to reach a better understanding of drug abuse. Mark H. Greene, MD Washington, DC

IN THE MEDICAL SERVICES MARKETPLACE Dr. M. E. Schaefer's article, in Public Health Briefs of your March, 1975, issue (65:293, 1975), strikes me as a very interesting and thoughtful treatment of "the concepts of demand, want, and need in the market for medical services." I do not remember the original article by Jeffers et al. (61:46, 1971), which Schaefer cites as his springboard, but I'm sure that together they cover a large assortment of implications and ramifications that should stimulate further reaction and discussion among readers. Particularly noteworthy are Schaefer's allusions to a variety of "externalities" in consumption and production. I would go further, to urge that these be regarded not as tangential considerations but as possibly sur-

passing in value the strictly economic or dollar-measured factors. Just as econometric market analyses on food would prompt me to contend for externalities that precede and transcend the values of a market-focused economy. And who, in that case, would resolve the problem of costing out the pleasure benefits (pain-avoidance, gourmandry, cuisinery) versus the survival benefits (life, vigor, creativity)? Beyond this, what are Schaefer's grounds for assuming that the choice of the patient (as user or consumer) is properly and necessarily overridden by the opinion of either the medical expert or the central planner?! My gestalt of the citizen in a free society provides him with the sovereign right of choice-in the exercise of which he will weigh (as he sees fit) the expert advice of the provider, the planner, and others. And, incidentally, why is economics constrained to deal with only the first of the three goal conceptions (demand, want, and need)? Is there no way to break out of the market frame of reference to conceive a Humanist Economics? Particularly when there is so much underutilization of our industrial resource, and so much slack in our development of the human resource! Finally, I perceive that Schaefer and Jeffers might not actually be so far apart as the technical argument suggests. When Schaefer acknowledges (at the end of p. 294) that "a positive consumption externality may occur if individual A's satisfaction is increased merely by knowing that individual B received some medical care," he has perhaps identified the very factor that underlies, sustains, and validates the Jeffers position favoring all the health care that is useful. Herman S. Solomon Associate Research Analyst New York State Department of Labor

OCCUPATIONAL HEALTH AND SAFETY The

articles

on occupational

safety and health in the January, LETTERS TO THE EDITOR

647

Letter: In the medical services marketplace.

and provide a rationale and direction for therapy in heroin use, a behavioral model would appear to be distinctly superior to others, including the co...
201KB Sizes 0 Downloads 0 Views